10.95
price up icon13.94%   1.34
 
loading
Gh Research Plc stock is traded at $10.95, with a volume of 94,500. It is up +13.94% in the last 24 hours and up +31.77% over the past month. GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. The company is focused on developing novel and proprietary Mebufotenin 5-Methoxy-N, N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.
See More
Previous Close:
$9.61
Open:
$9.59
24h Volume:
94,500
Relative Volume:
1.73
Market Cap:
$543.17M
Revenue:
-
Net Income/Loss:
$-32.32M
P/E Ratio:
-15.94
EPS:
-0.687
Net Cash Flow:
$-36.14M
1W Performance:
+18.51%
1M Performance:
+31.77%
6M Performance:
-17.55%
1Y Performance:
+77.18%
1-Day Range:
Value
$9.50
$11.09
1-Week Range:
Value
$8.50
$11.09
52-Week Range:
Value
$5.05
$14.99

Gh Research Plc Stock (GHRS) Company Profile

Name
Name
Gh Research Plc
Name
Phone
-
Name
Address
-
Name
Employee
49
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
GHRS's Discussions on Twitter

Compare GHRS with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
GHRS 10.95 543.17M 0 -32.32M -36.14M -0.687
VRTX 451.23 115.74B 10.63B -479.80M -1.35B 13.33
REGN 743.35 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 591.82 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 248.79 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 102.14 24.49B 3.30B -501.07M 1.03B 11.54

Gh Research Plc Stock (GHRS) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-16-22 Initiated H.C. Wainwright Buy
Jun-16-22 Initiated ROTH Capital Buy

Gh Research Plc Stock (GHRS) Latest News

pulisher
Nov 20, 2024

H.C. Wainwright maintains buy rating on GHRS shares, cites Q3 report - Investing.com

Nov 20, 2024
pulisher
Nov 20, 2024

GH Research (NASDAQ:GHRS) Trading Up 2%Time to Buy? - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

3 Fast-Growing Stocks Analysts See Doubling in Price - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Does GH Research (GHRS) Have the Potential to Rally 225.18% as Wall Street Analysts Expect? - Yahoo Finance

Nov 20, 2024
pulisher
Nov 20, 2024

GH Research (NASDAQ:GHRS) Given Buy Rating at HC Wainwright - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

Canaccord Genuity Group Issues Pessimistic Forecast for GH Research (NASDAQ:GHRS) Stock Price - Defense World

Nov 20, 2024
pulisher
Nov 19, 2024

GH Research Q3 2024 Results and Clinical Updates - TipRanks

Nov 19, 2024
pulisher
Nov 19, 2024

GH Research (NASDAQ:GHRS) Trading 1.2% HigherTime to Buy? - MarketBeat

Nov 19, 2024
pulisher
Nov 18, 2024

Short Interest in GH Research PLC (NASDAQ:GHRS) Increases By 7.3% - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

GH Research (NASDAQ:GHRS) Stock Price Up 3.3%Here's Why - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

GH Research shares hold Buy rating as Canaccord anticipates pivotal durability data in 2025 - Investing.com

Nov 18, 2024
pulisher
Nov 18, 2024

GH Research (NASDAQ:GHRS) Price Target Lowered to $28.00 at Canaccord Genuity Group - MarketBeat

Nov 18, 2024
pulisher
Nov 15, 2024

GH Research (NASDAQ:GHRS) Stock Price Up 0.1%Time to Buy? - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

RA Capital Management, L.P. Increases Stake in GH Research PLC - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

Health Stocks Slide as Trump Picks Industry Skeptic Kennedy - BNN Bloomberg

Nov 15, 2024
pulisher
Nov 14, 2024

GH Research reports deeper losses as DMT clinical trial costs mount - Green Market Report

Nov 14, 2024
pulisher
Nov 14, 2024

GH Research (NASDAQ:GHRS) Shares Up 0.2%Here's What Happened - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Lynx1 Capital Management LP's Strategic Acquisition in GH Resear - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

GH Research Reports Third Quarter 2024 Financial Results and Provides Business Updates - GlobeNewswire

Nov 14, 2024
pulisher
Nov 14, 2024

GH Research Completes Phase 2b Depression Trial Enrollment, Reports $12.1M Q3 Loss | GHRS Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 13, 2024

GH Research (NASDAQ:GHRS) Stock Price Up 3.8%Here's Why - MarketBeat

Nov 13, 2024
pulisher
Nov 12, 2024

GH Research (NASDAQ:GHRS) Stock Price Up 4.1%Still a Buy? - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

(GHRS) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Nov 12, 2024
pulisher
Nov 11, 2024

GH Research (NASDAQ:GHRS) Trading 3.1% HigherHere's What Happened - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

Intellia Thera CS (NTLA-Q) QuotePress Release - The Globe and Mail

Nov 11, 2024
pulisher
Nov 10, 2024

Guardant Health, Inc. (NASDAQ:GH) Shares Acquired by US Bancorp DE - Defense World

Nov 10, 2024
pulisher
Nov 10, 2024

We Think GH Research (NASDAQ:GHRS) Can Afford To Drive Business Growth - Yahoo Finance

Nov 10, 2024
pulisher
Nov 08, 2024

GH Research (NASDAQ:GHRS) Trading Up 0.6%What's Next? - MarketBeat

Nov 08, 2024
pulisher
Nov 07, 2024

Major Depressive Disorder Clinical Trials 2024: FDA Approvals, - openPR

Nov 07, 2024
pulisher
Nov 07, 2024

GH Research (NASDAQ:GHRS) Trading Down 0.9%Should You Sell? - MarketBeat

Nov 07, 2024
pulisher
Nov 06, 2024

GH Research (NASDAQ:GHRS) Trading Up 2.1%What's Next? - MarketBeat

Nov 06, 2024
pulisher
Nov 05, 2024

GH Research (NASDAQ:GHRS) Stock Price Up 0.6%Here's Why - MarketBeat

Nov 05, 2024
pulisher
Nov 04, 2024

GH Research (NASDAQ:GHRS) Trading Up 0.7%Here's What Happened - MarketBeat

Nov 04, 2024
pulisher
Nov 02, 2024

abrdn plc Raises Stock Holdings in Guardant Health, Inc. (NASDAQ:GH) - MarketBeat

Nov 02, 2024
pulisher
Nov 01, 2024

(GHRS) On The My Stocks Page - Stock Traders Daily

Nov 01, 2024
pulisher
Nov 01, 2024

GH Research (NASDAQ:GHRS) Shares Up 2.2%Time to Buy? - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Standard Chartered Bank Ghana PLC (SCB.gh) Q32024 Interim Report - AfricanFinancials

Nov 01, 2024
pulisher
Oct 31, 2024

GH Research PLC (NASDAQ:GHRS) Sees Significant Growth in Short Interest - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

GH Research (NASDAQ:GHRS) Shares Down 1%What's Next? - MarketBeat

Oct 31, 2024
pulisher
Oct 30, 2024

GH Research (NASDAQ:GHRS) Shares Up 2.8%Here's What Happened - MarketBeat

Oct 30, 2024
pulisher
Oct 29, 2024

GH Research (NASDAQ:GHRS) Trading Down 0.1%Here's Why - MarketBeat

Oct 29, 2024
pulisher
Oct 29, 2024

Acromegaly Market Innovations Investigated by Size, Share, Trends And Outlook Report 2024-2033 - WhaTech

Oct 29, 2024
pulisher
Oct 29, 2024

Psychedelic Drugs Industry Size, Growth Opportunities - openPR

Oct 29, 2024
pulisher
Oct 28, 2024

GH Research (NASDAQ:GHRS) Trading 3.3% HigherHere's Why - MarketBeat

Oct 28, 2024
pulisher
Oct 22, 2024

How To Trade (GHRS) - Stock Traders Daily

Oct 22, 2024
pulisher
Oct 22, 2024

Stanbic Bank facilitates GH¢200m bond issuance for Kasapreko PLC - Graphic Online

Oct 22, 2024
pulisher
Oct 21, 2024

GGBL announces dividend of GH¢0.022 per share for shareholders - Myjoyonline

Oct 21, 2024
pulisher
Oct 11, 2024

Objective long/short (GHRS) Report - Stock Traders Daily

Oct 11, 2024
pulisher
Oct 03, 2024

Tullow Oil Plc (TLW.gh) HY2024 Presentation - AfricanFinancials

Oct 03, 2024
pulisher
Sep 30, 2024

When (GHRS) Moves Investors should Listen - Stock Traders Daily

Sep 30, 2024
pulisher
Sep 28, 2024

Mackenzie Financial Corp Has $148.34 Million Holdings in Ferguson plc (NASDAQ:FERG) - Defense World

Sep 28, 2024

Gh Research Plc Stock (GHRS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$71.05
price up icon 0.69%
$18.62
price down icon 6.90%
$36.94
price down icon 0.94%
$364.33
price up icon 1.00%
$194.26
price up icon 3.46%
$102.14
price down icon 4.00%
Cap:     |  Volume (24h):